why choose us

First received: February 5, 2023

Clinical Trial: Dapagliflozin in the Treatment of Heart Failure

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Heart Failure

Study Type: Observational


Official Title: Safety and Efficacy of Dapagliflozin in the Treatment of Heart Failure in Non-diabetic Egyptian Patients

Brief Summary: prospectively evaluation the safety and efficacy of the Sodium-glucose Cotransporter-2 (SGLT2) inhibitor dapagliflozin in non-diabetic patients with heart failure and a reduced ejection fraction

Read more